Published in Br J Ophthalmol on November 01, 1997
Five years of surveillance. Br J Ophthalmol (2002) 0.94
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology (2001) 2.61
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02
Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology (2000) 1.75
Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye (Lond) (1997) 1.58
Questioning questionnaires. Eye (Lond) (2001) 1.58
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
Radioiodine and Graves' ophthalmopathy reconsidered. Nucl Med Commun (2001) 1.39
Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol (2000) 1.36
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol (2003) 1.30
Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol (2000) 1.26
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Visual loss and falls: a review. Eye (Lond) (2010) 1.11
HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens (1999) 1.10
Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ (1995) 1.09
Surgical treatment of superior bullous rhegmatogenous retinal detachments. Br J Ophthalmol (1985) 1.08
Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol (1999) 1.06
Acute retinal necrosis in children caused by herpes simplex virus. Retina (2001) 0.98
Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol (1996) 0.98
Streptococcus anginosus-associated endogenous endophthalmitis mimicking fungal endophthalmitis. J Clin Microbiol (2005) 0.98
Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol (1998) 0.95
Resolution of calcific band keratopathy after lowering elevated serum calcium in a patient with sarcoidosis. Br J Ophthalmol (1995) 0.95
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol (1998) 0.93
MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics (1999) 0.93
Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis. Br J Ophthalmol (1994) 0.91
Systematic review of ethnic variation in the phenotype of Behcet's disease. Scand J Rheumatol (2007) 0.90
The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye (Lond) (1994) 0.90
Systemic associations of retinal vasculitis. Int Ophthalmol Clin (1991) 0.89
Macular ischaemia in posterior uveitis. Eye (Lond) (1993) 0.89
Choroidal abnormalities in birdshot chorioretinopathy: an indocyanine green angiography study. Eye (Lond) (1997) 0.88
The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU). Clin Exp Immunol (1999) 0.88
Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification. Br J Ophthalmol (2004) 0.88
Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. Eur J Immunogenet (2000) 0.87
Tuberculous orbital apex syndromes. Br J Ophthalmol (2008) 0.86
Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis. Eye (Lond) (1996) 0.86
Behçet's disease in patients of west African and Afro-Caribbean origin. Br J Ophthalmol (2003) 0.86
Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens (2004) 0.86
The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells. J Neuroimmunol (2004) 0.85
Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients. Tissue Antigens (2005) 0.85
Neovascularisation associated with posterior uveitis. Br J Ophthalmol (1987) 0.85
Diagnosis of Treponema pallidum in vitreous samples using real time polymerase chain reaction. Br J Ophthalmol (2006) 0.84
The role of azathioprine in the management of retinal vasculitis. Eye (Lond) (1998) 0.84
Leukocyte trafficking in experimental autoimmune uveitis in vivo. J Leukoc Biol (1998) 0.84
Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome. Acta Ophthalmol Scand (2005) 0.84
Corticosteroid-induced osteoporosis in patients with uveitis. Eye (Lond) (2002) 0.83
Immunity and Toxoplasma retinochoroiditis. Clin Exp Immunol (2008) 0.83
Longitudinal analysis of soluble intercellular adhesion molecule 1 in retinal vasculitis patients. Eur J Clin Invest (1996) 0.83
Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis? Immunol Lett (2008) 0.83
The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye (Lond) (1999) 0.82
Expression of hematopoietic cell markers by retinal pigment epithelial cells. Curr Eye Res (1997) 0.82
Paraneoplastic retinopathy in association with large cell neuroendocrine bronchial carcinoma. Br J Ophthalmol (1995) 0.82
Expression analysis of immune response genes of Müller cells infected with Toxoplasma gondii. J Neuroimmunol (2006) 0.82
Soluble intercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) in patients with HIV/AIDS does not appear to correlate with cytomegalovirus retinitis. Int J STD AIDS (1998) 0.81
Sudden loss of vision caused by a vasculitic ophthalmic artery occlusion in a patient with ankylosing spondylitis and Crohn's disease. Br J Ophthalmol (2006) 0.81
Severe idiopathic posterior scleritis in children. Eye (Lond) (1995) 0.81
Gaze evoked amaurosis in dysthyroid orbitopathy. Br J Ophthalmol (1999) 0.80
Retinal vasculitis: correlation of animal and human disease. Eye (Lond) (1987) 0.80
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 2. Clinical relevance of antiretinal autoimmunity and circulating immune complexes. Br J Ophthalmol (1989) 0.80
Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease. Eur J Immunogenet (2004) 0.80
CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens (2008) 0.80
Prevalence of HLA B7 in MS with symptomatic uveitis. Lancet (1992) 0.80
Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease. Br J Ophthalmol (2001) 0.79
Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease. Clin Rheumatol (2006) 0.79
Soluble adhesion molecules in Behçet's disease. Ocul Immunol Inflamm (1998) 0.79
Behçet's syndrome. Br J Ophthalmol (2003) 0.78
Circulating immune complexes may play a regulatory and pathogenic role in experimental autoimmune uveoretinitis. Clin Exp Immunol (1992) 0.77
Hypopyon uveitis and iris nodules in non-Hodgkin's lymphoma: ocular relapse during systemic remission. Clin Oncol (R Coll Radiol) (2000) 0.77
A new method for studying the selective adherence of blood lymphocytes to the microvasculature of human retina. Invest Ophthalmol Vis Sci (1997) 0.77
Angiographic abnormalities of experimental autoimmune uveoretinitis. Curr Eye Res (1996) 0.77
Low prevalence of juvenile-onset Behcet's disease with uveitis in East/South Asian people. Br J Ophthalmol (2009) 0.77
Posterior segment complications of graft versus host disease after bone marrow transplantation. Br J Ophthalmol (2003) 0.77
The pathogenesis of diabetic retinopathy. Br J Ophthalmol (2004) 0.76
Immunopathogenesis and prevention of uveitis with the Behçet's disease-specific peptide linked to cholera toxin B. Adv Exp Med Biol (2003) 0.76
The effect of cytokines on the replication of T. gondii within rat retinal vascular endothelial cells. J Neuroimmunol (2000) 0.76
Retinopathy after irradiation and hyperbaric oxygen. J R Soc Med (1984) 0.76
Urinary neopterin in idiopathic retinal vasculitis. Br J Ophthalmol (2001) 0.75
The pituitary-adrenal axis in idiopathic retinal vasculitis. Br J Ophthalmol (1999) 0.75
Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease. Br J Ophthalmol (2003) 0.75
Non-caseating granulomas as a cause of ischaemic retinal vasculitis. Br J Ophthalmol (1997) 0.75
Inflammatory optic neuropathy as the presenting feature of herpes simplex acute retinal necrosis. Br J Ophthalmol (2003) 0.75
Natural history of diabetic macular streak exudates: evidence from a screening programme. Br J Ophthalmol (1999) 0.75
Uveitis initiating an autoimmune reaction resulting in Goodpasture's syndrome in a Chinese man. Br J Ophthalmol (2002) 0.75
Tolerance--will it end in tears? Eye (Lond) (1997) 0.75
Thrombophilia in isolated idiopathic retinal vasculitis. Lancet (1994) 0.75
Detection of retinal lesions after telemedicine transmission of digital images. Eye (Lond) (2000) 0.75
HACEK endocarditis causing endogenous endophthalmitis and a metastatic abscess. Eye (Lond) (2006) 0.75
Blood-stained keratic precipitates: presenting feature of sarcoidosis with thrombocytopenia. Eye (Lond) (2001) 0.75
Limitations of SCID-Hu mouse model for antiretinal autoantibody responses. Ocul Immunol Inflamm (1996) 0.75
Graves' disease presenting with bilateral acute painful proptosis, ptosis, ophthalmoplegia, and visual loss. Lancet (1984) 0.75
Pathogenicity and immunogenicity of recombinant human retinal S-antigen fusion protein. Curr Eye Res (1992) 0.75
Systemic morbidity in patients with isolated idiopathic retinal vasculitis. Lancet (1995) 0.75
Thrombophilic factors in ischaemic and non-ischaemic idiopathic retinal vasculitis. Eye (Lond) (1995) 0.75
Expression of haematopoietic cell markers by retinal pigment epithelial cells and Muller cells. Biochem Soc Trans (1997) 0.75
Acute retinal necrosis presenting as central retinal artery occlusion with cilioretinal sparing. Eur J Ophthalmol (2005) 0.75